Tumor-targeted efficiency of shRNA vector harboring chimera hTERT/U6 promoter

Oncology Reports

Volumn 23, Issue 5, 2010, Pages 1309-1316

  Zhang, Penghui ^a   Chen, Yaqin ^a   Jiang, Xixin ^a   Tu, Zhiguang ^a   Zou, Lin ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Human telomerase reverse transcriptase; Promoter; Short hairpin RNA; Telomerase; Tumor targeted

Indexed keywords

ENHANCED GREEN FLUORESCENT PROTEIN; GREEN FLUORESCENT PROTEIN; SHORT HAIRPIN RNA; TELOMERASE REVERSE TRANSCRIPTASE;

ARTICLE; CONTROLLED STUDY; FIBROBLAST; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LIVER CELL CARCINOMA; PRIORITY JOURNAL; RNA VECTOR;

ANIMALS; CARCINOMA, HEPATOCELLULAR; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE THERAPY; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; HEP G2 CELLS; HUMANS; LIVER NEOPLASMS; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; PROMOTER REGIONS, GENETIC; RNA INTERFERENCE; RNA, SMALL INTERFERING; RNA, SMALL NUCLEAR; TELOMERASE; TIME FACTORS; TUMOR BURDEN; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 77950842157     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or_00000765     Document Type: Article

References (28)

1. Greider CW: Telomere length regulation. Annu Rev Biochem 65: 337-365, 1996.
2. Cervantes RB and Lundblad V: Mechanisms of chromosomeend protection. Curr Opin Cell Biol 14: 351-356, 2002.
3. Shay JW and Wright WE: Senescence and immortalization: role of telomeres and telomerase. Carcinogenesis 26: 867-874, 2005.
4. Feng J, Funk WD, Wang SS, et al: The RNA component of human telomerase. Science 269: 1236-1241, 1995.
5. Nakamura TM, Morin GB, Chapman KB, et al: Telomerase catalytic subunit homologs from fission yeast and human. Science 277: 955-959, 1997.
6. Wu KJ, Grandori C, Amacker M, et al: Direct activation of TERT transcription by c-myc. Nat Genet 21: 220-224, 1999.
7. Kim SH, Chung HK, Kang JH, et al: Tumor-targeted radionuclide imaging and therapy based on human sodium iodide symporter gene driven by a modified telomerase reverse transcriptase promoter. Hum Gene Ther 19: 951-957, 2008.
8. Shay JW and Wright WE: Telomerase: A target for cancer therapeutics. Cancer Cell 2: 257-265, 2002.
9. Ichim TE, Li M, Qian H, et al: RNA interference: a potent tool for gene-specific therapeutics. Am J Transplant 4: 1227-1236, 2004.
10. Hannon GJ and Rossi JJ: Unlocking the potential of the human genome with RNA interference. Nature 431: 371-378, 2004.
11. Dykxhoorn DM, Novina CD and Sharp PA: Killing the messenger: short RNAs that silence gene expression. Nat Rev Mol Cell Biol 4: 457-467, 2003.
12. Meister G and Tuschl T: Mechanisms of gene silencing by double-stranded RNA. Nature 431: 343-349, 2004.
13. An DS, Xie Y, Mao SH, et al: Efficient lentiviral vectors for short hairpin RNA delivery into human cells. Hum Gene Ther 14: 1207-1212, 2003.
14. Zhang PH, Zou L and Tu ZG: RNAi-hTERT inhibition hepatocellular carcinoma cell proliferation via decreasing telomerase activity. J Surg Res 131: 143-149, 2006.
15. Nishi H, Nakada T, Kyo S, et al: Hypoxia-inducible factor 1 mediates upregulation of telomerase (hTERT). Mol Cell Biol 24: 6076-6083, 2004.
16. Collins I and Workman P: New approaches to molecular cancer therapeutics. Nat Chem Biol 2: 689-700, 2006.
17. Soifer HS, Rossi JJ and Sætrom P: MicroRNAs in disease and potential therapeutic applications. Mol Ther 15: 2070-2079, 2007.
18. Hauf S, Cole RW, LaTerra S, et al: The small molecule Hesperadin reveals a role for Aurora B in correcting kinetochoremicrotubule attachment and in maintaining the spindle assembly checkpoint. J Cell Biol 161: 281-294, 2003.
19. Chen Y, Stamatoyannopoulos G and Song CZ: Down-regulation of CXCR4 by inducible small interfering RNA inhibits breast cancer cell invasion in vitro. Cancer Res 63: 4801-4804, 2003.
20. Jackson AL and Linsley PS: Noise amidst the silence: off-target effects of siRNAs? Trends Genet 20: 521-524, 2004.
21. Sledz CA, Holko M, de Veer MJ, et al: Activation of the interferon system by short-interfering RNAs. Nat Cell Biol 5: 834-839, 2003.
22. Golzio M, Mazzolini L, Ledoux A, et al: In vivo gene silencing in solid tumors by targeted electrically mediated siRNA delivery. Gene Ther 14: 752-759, 2007.
23. Fedorov Y, Anderson EM, Birmingham A, et al: Off-target effects by siRNA can induce toxic phenotype. RNA 12: 1188-1196, 2006.
24. Dorsett Y and Tuschl T: siRNAs: applications in functional genomics and potential as therapeutics. Nat Rev Drug Discov 3: 318-329, 2004.
25. Paddison PJ, Silva JM, Conklin DS, et al: A resource for largescale RNA-interference-based screens in mammals. Nature 428: 427-431, 2004.
26. Kim B, Tang Q, Biswas PS, et al: Inhibition of ocular angiogenesis by siRNA targeting vascular endothelial growth factor pathway genes: therapeutic strategy for herpetic stromal keratitis. Am J Pathol 165: 2177-2185, 2004.
27. Ding SW and Voinnet O: Antiviral immunity directed by small RNAs. Cell 130: 413-426, 2007.
28. Takei Y, Kadomatsu K, Yuzawa Y, et al: A small interfering RNA targeting vascular endothelial growth factor as cancer therapeutics. Cancer Res 64: 3365-3370, 2004.